Skip to main navigation Skip to search Skip to main content

Clinical Utility of [18F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma

  • Jana Ivanidze
  • , Kellen Vo Vu
  • , Rongwei Fu
  • , Andrew Brandmaier
  • , Laszlo Szidonya
  • , Gagandeep Choudhary
  • , Jay Starkey
  • , Tony J. Wang
  • , Michael Sisti
  • , L. Guy Mckhann
  • , Sushant Puri
  • , Marcus Konner
  • , Michelle Roytman
  • , Eaton Lin
  • , Andrew Kuhn
  • , Joseph R. Osborne
  • , Philip E. Stieg
  • , Kathryn Beal
  • , Rohan R. Ramakrishna
  • , Gagandeep Singh
    • Angela Lignelli-Dipple, Mikhail Doubrovin, Anh Huan Vo, Mary Welch, Fabio Iwamoto, Aya Haggiagi, Laura Donovan, Maria Diaz Ordonez, Brian Gill, Benjamin Liechty, David J. Pisapia, Josh Walker, Rajiv S. Magge, Matthew Wood, Valentina Marulanda Corzo, Olabisi R. Sanusi, Ahmed Raslan, Aclan Dogan, Stephen Bowden, Sadek A. Nehmeh, Joshua Nickerson, Nadine Mallak, Amber Ruiz, Prakash Ambady, Ali Nabavizadeh, Ramon F. Barajas

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Utility of [18F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Neuroscience